Cardiology Research, ISSN 1923-2829 print, 1923-2837 online, Open Access
Article copyright, the authors; Journal compilation copyright, Cardiol Res and Elmer Press Inc
Journal website https://cr.elmerpub.com

Original Article

Volume 000, Number 000, June 2025, pages 000-000


Remimazolam for Procedural Sedation During Cardioversion

Table

Table 1. Clinical Patient Data and Remimazolam Dosing
 
Patient numberDemographics (age, weight, height, gender)Remimazolam dosingAdjunctive agentsOutcomes and follow-up
151-year-old, 70.2 kg, 175 cm, man3.51 mg bolus followed by a continuous infusion at 10 - 20 µg/kg/min duration preparation and performance of the procedure.Fentanyl 100 µgSuccessful cardioversion. Recovery time of 62 min. Discharged home the same day.
222-year-old, 63.9 kg, 174 cm, man5 mg bolus followed by a continuous infusion at 10 - 20 µg/kg/min duration preparation and performance of the procedure.Fentanyl 100 µgSuccessful cardioversion. Recovery time of 65 min. Reported nausea and pain. Received ondansetron and acetaminophen. Discharged home the same day.
368-year-old, 81.8 kg, 177 cm, man5 mg bolusNoneSuccessful cardioversion. Recovery time of 54 min. Discharged home the same day, expired at home 3 months later.
449-year-old, 81.6 kg, 178 cm, man5 mg bolusNoneSuccessful cardioversion. Recovery time of 43 min. Remained inpatient for dofetilide initiation. Discharged home 4 days later.
542-year-old, 66.3 kg, 172 cm, man5 mg bolusNoneSuccessful cardioversion. Recovery time of 20 min. Discharged home the next day.
634-year-old, 150.4 kg, 179 cm, man5 mg bolusNoneSuccessful cardioversion. Recovery time of 30 min. Remained inpatient for initiation of sotalol therapy.